Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in Community vs Specialized Hospitals
Outcomes After Brexucabtagene Autoleucel as First Post-Inotuzumab Therapy in Relapsed ALL
Outpatient CAR T-Cell Therapy Administration in Hematologic Malignancies
Post-Transplant Cyclophosphamide and Infection Risk after Allogeneic HCT
Emerging Therapies for Aggressive Follicular Lymphoma
CAR T-Cell Therapy for Non-Hodgkin Lymphoma: Outpatient Feasibility
Changing Role of Allogeneic Transplant in Adult B-ALL in the CAR T Era
Quality of Life after Hematopoietic Cell Transplantation: 10-Year Survivorship Study
Long-Term Survivorship after Hematopoietic Cell Transplantation
Consensus on Late Effects after Blood and Marrow Transplant
Titles as indexed on PubMed.